Xeris Biopharma Holdings, Inc. (XERS) — research page
US · us-cm-kg/NASDAQ/XERS · as of 2026-11-08
Identity and listing
The issuer is Xeris Biopharma Holdings, Inc., listed on NASDAQ under ticker XERS, with ISIN US98422E1038. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US exists. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the segment and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Xeris Biopharma Holdings, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | XERS | source · 2026-11-08 |
| ISIN | US98422E1038 | source · 2026-09-30 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 97 filings across 56 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 3 days. The latest filing is dated 2026-11-06, two days before the record date of 2026-11-08, and is of type directors_dealings. Filings by type are: directors_dealings 50, regulatory_filing 26, results 9, corporate_news 6, director_change 3, and agm_egm 3. The NASDAQ exchange median is 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days, across 4359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days, across 526 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 97 | 3 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | directors_dealings | 4 | 4 — FORM 4 |
| 2026-11-05 | regulatory_filing | 144 | 144 |
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-05 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-11-04 | directors_dealings | 4 | 4 — FORM 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Ernst & Young LLP, located in Grand Rapids, Michigan. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page; the count is 0.
Open research
No openly published research notes were found on the record; the count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001867096.json (identity.name)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/XERS (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1867096/000186709626000016/xers-20251231.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/XERS (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US98422E1038"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c334f9b19845cb50.